From: Metabolic syndrome and the incidence of lung cancer: a meta-analysis of cohort studies
Studies omitted | HR | 95% CI | I2 | P for effect |
---|---|---|---|---|
Russo 2008 | 0.91 | 0.80 to 1.05 | 0 | 0.21 |
Inoue 2009-M | 0.94 | 0.84 to1.06 | 0 | 0.32 |
Inoue 2009-F | 0.95 | 0.85 to1.06 | 0 | 0.35 |
Osaki 2012-M | 0.96 | 0.85 to1.07 | 0 | 0.44 |
Osaki 2012-F | 0.93 | 0.83 to1.04 | 0 | 0.22 |
Kruijsdijk 2013 | 0.95 | 0.83 to1.04 | 0 | 0.23 |
Ko 2016-M | 0.93 | 0.81 to1.05 | 0 | 0.24 |
Ko 2016-F | 0.94 | 0.84 to 1.65 | 0 | 0.28 |